ReviewMolecular medicine (Cambridge, Mass.)2022

RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Mengyi Lao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.